Folic Acid

References

1. ^ a b Kawashima A, et al. Four week supplementation with mixed fruit and vegetable juice concentrates increased protective serum antioxidants and folate and decreased plasma homocysteine in Japanese subjects. Asia Pac J Clin Nutr. (2007)
2. ^ a b Czeizel AE, Dudás I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. (1992)
3. ^ Almeida OP, et al. B-vitamins reduce the long-term risk of depression after stroke: The VITATOPS-DEP trial. Ann Neurol. (2010)
4. ^ Ford AH, et al. Vitamins B12, B6, and folic acid for onset of depressive symptoms in older men: results from a 2-year placebo-controlled randomized trial. J Clin Psychiatry. (2008)
5. ^ a b c Christensen H, et al. No clear potentiation of antidepressant medication effects by folic acid+vitamin B12 in a large community sample. J Affect Disord. (2011)
6. ^ a b Ji HF, Tang GY, Zhang HY. A theoretical study on the structure-activity relationships of metabolites of folates as antioxidants and its implications for rational design of antioxidants. Bioorg Med Chem. (2005)
7. ^ Miller AL. The methylation, neurotransmitter, and antioxidant connections between folate and depression. Altern Med Rev. (2008)
8. ^ Florio R, et al. Serine hydroxymethyltransferase: a model enzyme for mechanistic, structural, and evolutionary studies. Biochim Biophys Acta. (2011)
9. ^ Bhargava S, Tyagi SC. Nutriepigenetic regulation by folate-homocysteine-methionine axis: a review. Mol Cell Biochem. (2014)
10. ^ Mato JM, et al. S-adenosylmethionine synthesis: molecular mechanisms and clinical implications. Pharmacol THer. (1997)
11. ^ Turner MA, et al. Structure and function of S-adenosylhomocysteine hydrolase. Cell Biochem Biophys. (2000)
12. ^ a b c d e Institute of Medicine. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Institute of Medicine. (1998)
13. ^ Crider KS, Bailey LB, Berry RJ. Folic acid food fortification-its history, effect, concerns, and future directions. Nutrients. (2011)
14. ^ Craig GM, Elliot C, Hughes KR. Masked vitamin B12 and folate deficiency in the elderly. Br J Nutr. (1985)
15. ^ Ellison AB. Pernicious anemia masked by multivitamins containing folic acid. J Am Med Assoc. (1960)
16. ^ Allen RH, et al. Diagnosis of cobalamin deficiency I: usefulness of serum methylmalonic acid and total homocysteine concentrations. Am J Hematol. (1990)
17. ^ Crosby WH. The danger of folic acid in multivitamin preparations. Mil Med. (1960)
18. ^ a b Agamanolis DP, et al. Neuropathology of experimental vitamin B12 deficiency in monkeys. Neurology. (1976)
19. ^ a b c Morris MS, et al. Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr. (2007)
20. ^ a b Hunter R, et al. Toxicity of folic acid given in pharmacological doses to healthy volunteers. Lancet. (1970)
21. ^ a b Gibberd FB, et al. Toxicity of folic acid. Lancet. (1970)
22. ^ a b Hellström L. Lack of toxicity of folic acid given in pharmacological doses to healthy volunteers. Lancet. (1971)
23. ^ a b Richens A. Toxicity of folic acid. Lancet. (1971)
24. ^ a b Sheehy TW. Folic acid: lack of toxicity. Lancet. (1973)
25. ^ a b Suarez RM, Spies TD, Suarez RM Jr.. The use of folic acid in sprue. Ann Intern Med. (1947)
26. ^ a b c d e f Kelly P, et al. Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements. Am J Clin Nutr. (1997)
27. ^ a b c d Sweeney MR, McPartlin J, Scott J. Folic acid fortification and public health: report on threshold doses above which unmetabolised folic acid appear in serum. BMC Public Health. (2007)
28. ^ a b c d e Troen AM et al.. Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J Nutr. (2006)
29. ^ Morris MS, et al. Circulating unmetabolized folic acid and 5-methyltetrahydrofolate in relation to anemia, macrocytosis, and cognitive test performance in American seniors. Am J Clin Nutr. (2010)
30. ^ a b c d Christensen KE et al.. High folic acid consumption leads to pseudo-MTHFR deficiency, altered lipid metabolism, and liver injury in mice. Am J Clin Nutr. (2015)
31. ^ Lok A et al.. The one-carbon-cycle and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in recurrent major depressive disorder; influence of antidepressant use and depressive state?. J Affect Disord. (2014)
32. ^ a b c d Wright AJ, Dainty JR, Finglas PM. Folic acid metabolism in human subjects revisited: potential implications for proposed mandatory folic acid fortification in the UK. Br J Nutr. (2007)
33. ^ Obeid R. The metabolic burden of methyl donor deficiency with focus on the betaine homocysteine methyltransferase pathway. Nutrients. (2013)
34. ^ Liew SC, Gupta ED. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases. Eur J Med Genet. (2015)
35. ^ a b Yan J et al.. MTHFR C677T genotype influences the isotopic enrichment of one-carbon metabolites in folate-compromised men consuming d9-choline. Am J Clin Nutr. (2011)
36. ^ a b c d e f Gilbody S, Lewis S, Lightfoot T. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. Am J Epidemiol. (2007)
37. ^ Rozen R. Molecular genetics of methylenetetrahydrofolate reductase deficiency. J Inherit Metab Dis. (1996)
38. ^ Lievers KJ et al.. A second common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme activity, homocysteine, and cardiovascular disease risk. J Mol Med (Berl). (2001)
39. ^ Goyette P, et al. Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency. Am J Hum Genet. (1995)
40. ^ Goyette P, et al. Severe and mild mutations in cis for the methylenetetrahydrofolate reductase (MTHFR) gene, and description of five novel mutations in MTHFR. Am J Hum Genet. (1996)
41. ^ Trembath D et al.. Analysis of select folate pathway genes, PAX3, and human T in a Midwestern neural tube defect population. Teratology. (1999)
42. ^ a b Botto LD, Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol. (2000)
43. ^ Vandana Rai, et al. Maternal Methylenetetrahydrofolate Reductase C677T Polymorphism and Down Syndrome Risk: A Meta-Analysis from 34 Studies. PLoS One. (2014)
44. ^ a b c Sharp L, Little J. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am J Epidemiol. (2004)
45. ^ Bjelland I, et al. Folate, vitamin B12, homocysteine, and the MTHFR 677C->T polymorphism in anxiety and depression: the Hordaland Homocysteine Study. Arch Gen Psychiatry. (2003)
46. ^ Lewis SJ, Ebrahim S, Davey Smith G. Meta-analysis of MTHFR 677C->T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate?. BMJ. (2005)
47. ^ David S Wald, Malcolm Law, and Joan K Morris. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ. (2002)
48. ^ Robien K, Ulrich CM. 5,10-Methylenetetrahydrofolate Reductase Polymorphisms and Leukemia Risk: A HuGE Minireview. Am J Epidemiol. (2003)
49. ^ Chandler CJ, Wang TT, Halsted CH. Pteroylpolyglutamate hydrolase from human jejunal brush borders. Purification and characterization. J Biol Chem. (1986)
50. ^ a b Strum WB. Enzymatic reduction and methylation of folate following pH-dependent, carrier-mediated transport in rat jejunum. Biochim Biophys Acta. (1979)
51. ^ Bhandari SD, Gregory JF 3rd. Folic acid, 5-methyl-tetrahydrofolate and 5-formyl-tetrahydrofolate exhibit equivalent intestinal absorption, metabolism and in vivo kinetics in rats. J Nutr. (1992)
52. ^ Clifford AJ, et al. The dynamics of folic acid metabolism in an adult given a small tracer dose of 14C-folic acid. Adv Exp Med Biol. (1998)
53. ^ Krumdieck CL, et al. A long-term study of the excretion of folate and pterins in a human subject after ingestion of 14C folic acid, with observations on the effect of diphenylhydantoin administration. Am J Clin Nutr. (1978)
54. ^ Rogers LM, et al. A dual-label stable-isotopic protocol is suitable for determination of folate bioavailability in humans: evaluation of urinary excretion and plasma folate kinetics of intravenous and oral doses of {13C5} and {2H2}folic acid. J Nutr. (1997)
55. ^ a b Steinberg SE, Campbell CL, Hillman RS. Kinetics of the normal folate enterohepatic cycle. J Clin Invest. (1979)
56. ^ Steinberg SE. Mechanisms of folate homeostasis. Am J Physiol. (1984)
57. ^ V. Michael Whitehead, et al. Intestinal Conversion of Folinic Acid to 5-Methyltetrahydrofolate in Man. Br J Haematol. (1972)
58. ^ Smith ME, Matty AJ, Blair JA. The transport of pteroylglutamic acid across the small intestine of the rat. Biochim Biophys Acta. (1970)
59. ^ Tani M, Iwai K. High-performance liquid chromatographic separation of physiological folate monoglutamate compounds. Investigation of absorption and conversion of pteroylglutamic acid in the small intestine of the rat in situ. J CHromatogr. (1983)
60. ^ Masters JN, Attardi G. The nucleotide sequence of the cDNA coding for the human dihydrofolic acid reductase. Gene. (1983)
61. ^ Obeid R, et al. Concentrations of unmetabolized folic acid and primary folate forms in plasma after folic acid treatment in older adults. Metabolism. (2011)
62. ^ Matherly LH, Hou Z, Deng Y. Human reduced folate carrier: translation of basic biology to cancer etiology and therapy. Cancer Metastasis Rev. (2007)
63. ^ Leamon CP, Jackman AL. Exploitation of the folate receptor in the management of cancer and inflammatory disease. Vitam Horm. (2008)
64. ^ a b c d e Zhao R, et al. Mechanisms of membrane transport of folates into cells and across epithelia. Annu Rev Nutr. (2011)
65. ^ Zhao R, et al. Impact of the reduced folate carrier on the accumulation of active thiamin metabolites in murine leukemia cells. J Biol Chem. (2001)
66. ^ Zhao R, Matherly LH, Goldman ID. Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissues. Expert Rev Mol Med. (2009)
67. ^ Whetstine JR, Flatley RM, Matherly LH. The human reduced folate carrier gene is ubiquitously and differentially expressed in normal human tissues: identification of seven non-coding exons and characterization of a novel promoter. Biochem J. (2002)
68. ^ Goldman ID, et al. The antifolates: evolution, new agents in the clinic, and how targeting delivery via specific membrane transporters is driving the development of a next generation of folate analogs. Curr Opin Investig Drugs. (2010)
69. ^ Said et al.. Adaptive regulation of intestinal folate uptake: effect of dietary folate deficiency. Am J Physiol Cell Physiol. (2000)
70. ^ a b Liu M et al.. Structure and regulation of the murine reduced folate carrier gene: identification of four noncoding exons and promoters and regulation by dietary folates. J Biol Chem. (2005)
71. ^ a b Kamen BA, Smith AK. A review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitro. Adv Drug Deliv Rev. (2004)
72. ^ Ross JF, et al. Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia. Cancer. (1999)
73. ^ Wang H, et al. Differentiation-independent retinoid induction of folate receptor type beta, a potential tumor target in myeloid leukemia. Blood. (2000)
74. ^ a b c Yamaguchi T et al.. Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor. Immunity. (20007)
75. ^ Shen F, et al. Folate receptor type gamma is primarily a secretory protein due to lack of an efficient signal for glycosylphosphatidylinositol modification: protein characterization and cell type specificity. Biochemistry. (1995)
76. ^ Piedrahita JA et al.. Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development. Nat Genet. (1999)
77. ^ Qiu A et al.. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell. (2006)
78. ^ a b Wang Y, Zhao R, Goldman ID. Characterization of a folate transporter in HeLa cells with a low pH optimum and high affinity for pemetrexed distinct from the reduced folate carrier. Clin Cancer Res. (2004)
79. ^ a b Zhao R, et al. Selective preservation of pemetrexed pharmacological activity in HeLa cells lacking the reduced folate carrier: association with the presence of a secondary transport pathway. Cancer Res. (2004)
80. ^ Shayeghi M et al.. Identification of an intestinal heme transporter. Cell. (2005)
81. ^ Qiu A et al.. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell. (2006)
82. ^ a b Ormazabal A et al.. Determination of 5-methyltetrahydrofolate in cerebrospinal fluid of paediatric patients: reference values for a paediatric population. Clin Chim Acta. (2006)
83. ^ Reynolds EH, Mattson RH, Gallagher BB. Relationships between serum and cerebrospinal fluid anticonvulsant drug and folic acid concentrations in epileptic patients. Neurology. (1972)
84. ^ a b Wesson VA, Levitt AJ, Joffe RT. Change in folate status with antidepressant treatment. Psychiatry Res. (1994)
85. ^ a b Fava M, et al. Folate, vitamin B12, and homocysteine in major depressive disorder. Am J Psychiatry. (1997)
86. ^ a b c Gilbody S, Lightfoot T, Sheldon T. Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity. J Epidemiol Community Health. (2007)
87. ^ a b c Ginsberg LD, Oubre AY, Daoud YA. L-methylfolate Plus SSRI or SNRI from Treatment Initiation Compared to SSRI or SNRI Monotherapy in a Major Depressive Episode. Innov Clin Neurosci. (2011)
88. ^ a b c d e f g Wollack JB et al.. Characterization of folate uptake by choroid plexus epithelial cells in a rat primary culture model. J Neurochem. (2008)
89. ^ Serot JM, et al. CSF-folate levels are decreased in late-onset AD patients. J Neural Transm (Vienna). (2001)
90. ^ Moretti P et al.. Cerebral folate deficiency with developmental delay, autism, and response to folinic acid. Neurology. (2005)
91. ^ Gilbody S, Lewis S, Lightfoot T. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. Am J Epidemiol. (2007)
92. ^ Wu D, Pardridge WM. Blood-brain barrier transport of reduced folic acid. Pharm Res. (1999)
93. ^ Zhao et al.. The spectrum of mutations in the PCFT gene, coding for an intestinal folate transporter, that are the basis for hereditary folate malabsorption. Blood. (2007)
94. ^ a b Baxter MG, Miller AA, Webster RA. Some studies on the convulsant action of folic acid. Br J Pharmacol. (1973)
95. ^ a b Kehl SJ, McLennan H, Collingridge GL. Effects of folic and kainic acids on synaptic responses of hippocampal neurones. Neuroscience. (1984)
96. ^ a b Weller M, et al. The reduced unsubstituted pteroate moiety is required for folate toxicity of cultured cerebellar granule neurons. J Pharmacol Exp Ther. (1994)
97. ^ a b Olney JW, et al. Intrastriatal folic acid mimics the distant but not local brain damaging properties of kainic acid. Neurosci Lett. (1981)
98. ^ a b Selhub J, et al. Folate-vitamin B-12 interaction in relation to cognitive impairment, anemia, and biochemical indicators of vitamin B-12 deficiency. Am J Clin Nutr. (2009)
99. ^ Quan FS, et al. Protective effects of folic acid against central nervous system neurotoxicity induced by lead exposure in rat pups. Genet Mol Res. (2015)
100. ^ Solon O, et al. Associations between cognitive function, blood lead concentration, and nutrition among children in the central Philippines.
101. ^ Lee MG, Chun OK, Song WO. Determinants of the blood lead level of US women of reproductive age. J Am Coll Nutr. (2005)
102. ^ Budni J et al.. Neurotoxicity induced by dexamethasone in the human neuroblastoma SH-SY5Y cell line can be prevented by folic acid. Neuroscience. (2011)
103. ^ Lin Y, et al. Group B vitamins protect murine cerebellar granule cells from glutamate/NMDA toxicity. Neuroreport. (2004)
104. ^ Yu HL, et al. Neuroprotective effects of genistein and folic acid on apoptosis of rat cultured cortical neurons induced by beta-amyloid 31-35. Br J Nutr. (2009)
105. ^ Tagliari B, et al. Hyperhomocysteinemia increases damage on brain slices exposed to in vitro model of oxygen and glucose deprivation: prevention by folic acid. Int J Dev Neurosci. (2006)
106. ^ Bjelland I, et al. Folate, vitamin B12, homocysteine, and the MTHFR 677C->T polymorphism in anxiety and depression: the Hordaland Homocysteine Study. Arch Gen Psychiatry. (2003)
107. ^ Kelly CB et al.. The MTHFR C677T polymorphism is associated with depressive episodes in patients from Northern Ireland. J Psychopharmacol. (2004)
108. ^ Almeida OP, et al. Contribution of the MTHFR gene to the causal pathway for depression, anxiety and cognitive impairment in later life. Neurobiol Aging. (2005)
109. ^ Carney MW, Sheffield BF. Serum folic acid and B12 in 272 psychiatric in-patients. Psychol Med. (1978)
110. ^ Ramos MI, et al. Plasma folate concentrations are associated with depressive symptoms in elderly Latina women despite folic acid fortification. Am J Clin Nutr. (2004)
111. ^ Sachdev PS, et al. Relationship of homocysteine, folic acid and vitamin B12 with depression in a middle-aged community sample. Psychol Med. (2005)
112. ^ Tolmunen T et al.. Dietary folate and the risk of depression in Finnish middle-aged men. A prospective follow-up study. Psychother Psychosom. (2004)
113. ^ Papakostas GI et al.. The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine. Int J Neuropsychopharmacol. (2005)
114. ^ Coppen A, Bailey J. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial. J Affect Disord. (2000)
115. ^ Passeri M et al.. Oral 5′-methyltetrahydrofolic acid in senile organic mental disorders with depression: results of a double-blind multicenter study. Aging (Milano). (1993)
116. ^ Godfrey PS et al.. Enhancement of recovery from psychiatric illness by methylfolate. Lancet. (1990)
117. ^ Taylor MJ, et al. Folate for depressive disorders. Cochrane Database Syst Rev. (2003)
118. ^ Loria-Kohen V, et al. A pilot study of folic acid supplementation for improving homocysteine levels, cognitive and depressive status in eating disorders. Nutr Hosp. (2013)
119. ^ a b Venkatasubramanian R, Kumar CN, Pandey RS. A randomized double-blind comparison of fluoxetine augmentation by high and low dosage folic acid in patients with depressive episodes. J Affect Disord. (2013)
120. ^ a b Papakostas GI et al.. L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials. Am J Psychiatry. (2012)
121. ^ a b Bedson E et al.. Folate Augmentation of Treatment–Evaluation for Depression (FolATED): randomised trial and economic evaluation. Health Technol Assess. (2014)
122. ^ Sharpley AL, et al. Folic acid supplementation for prevention of mood disorders in young people at familial risk: a randomised, double blind, placebo controlled trial. J Affect Disord. (2014)
123. ^ Moens AL, Kass DA. Tetrahydrobiopterin and cardiovascular disease. Arterioscler Thromb Vasc Biol. (2006)
124. ^ Naseem KM. The role of nitric oxide in cardiovascular diseases. Mol Aspects Med. (2005)
125. ^ Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutr J. (2015)
126. ^ Zhang M, et al. High‑dose folic acid improves endothelial function by increasing tetrahydrobiopterin and decreasing homocysteine levels. Mol Med Rep. (2014)
127. ^ Moat SJ et al.. High- but not low-dose folic acid improves endothelial function in coronary artery disease. Eur J Clin Invest. (2006)
128. ^ Low PS, Kularatne SA. Folate-targeted therapeutic and imaging agents for cancer. Curr Opin Chem Biol. (2009)
129. ^ Iyer SS et al.. Identification of novel markers for mouse CD4(+) T follicular helper cells. Eur J Immunol. (2013)
130. ^ Jia at el.. A novel splice variant of FR4 predominantly expressed in CD4+CD25+ regulatory T cells. Immunol Invest. (2009)
131. ^ a b Tian Y et al.. A novel splice variant of folate receptor 4 predominantly expressed in regulatory T cells.. BMC Immunol. (2012)
132. ^ Rogers EJ, Chen S, Chan A. Folate deficiency and plasma homocysteine during increased oxidative stress. N Engl J Med. (2007)
133. ^ Kruman II, et al. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci. (2000)
134. ^ a b Kruman II et al.. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer’s disease. J Neurosci. (2002)
135. ^ a b Guo X et al.. Protective Effect of Folic Acid on Oxidative DNA Damage: A Randomized, Double-Blind, and Placebo Controlled Clinical Trial. Medicine (Baltimore). (2015)
136. ^ Valavanidis A, Vlachogianni T, Fiotakis C. 8-hydroxy-2′ -deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. (2009)
137. ^ Sutton M, Daly LE, Kirke PN. Survival and disability in a cohort of neural tube defect births in Dublin, Ireland. Birth Defects Res A Clin Mol Teratol. (2008)
138. ^ Hibbard BM, Hibbard ED, Jeffcoate TN. Folic acid and reproduction. Acta Obstet Gynecol Scand. (1965)
139. ^ NA. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep. (1992)
140. ^ U.S. Preventive Services Task Force. Folic acid for the prevention of neural tube defects: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. (2009)
141. ^ Lewis AS. Rabbit brain purine nucleoside phosphorylase. Physical and chemical properties. Inhibition studies with aminopterin, folic acid and structurally related compounds. Arch Biochem Biophys. (1978)
142. ^ Hollinger JL, et al. In vitro studies of 5, 10-methylenetetrahydrofolate reductase: inhibition by folate derivatives, folate antagonists, and monoamine derivatives. J Neurochem. (1982)
143. ^ Baggott JE, Vaughn WH, Hudson BB. Inhibition of 5-aminoimidazole-4-carboxamide ribotide transformylase, adenosine deaminase and 5′-adenylate deaminase by polyglutamates of methotrexate and oxidized folates and by 5-aminoimidazole-4-carboxamide riboside and ribotide. Biochem J. (1986)
144. ^ Allegra CJ, et al. Inhibition of phosphoribosylaminoimidazolecarboxamide transformylase by methotrexate and dihydrofolic acid polyglutamates. Proc Natl Acad Sci U S A. (1985)
145. ^ Reeves PG. Components of the AIN-93 diets as improvements in the AIN-76A diet. J Nutr. (1997)
146. ^ Hollinger JL, et al. In vitro studies of 5, 10-methylenetetrahydrofolate reductase: inhibition by folate derivatives, folate antagonists, and monoamine derivatives. J Neurochem. (1982)
147. ^ Farias N, et al. The effects of folic acid on global DNA methylation and colonosphere formation in colon cancer cell lines. J Nutr Biochem. (2015)
148. ^ Kim Yi. Folate and colorectal cancer: an evidence-based critical review. Mol Nutr Food Res. (2007)
149. ^ Giovannucci E. Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr. (2002)
150. ^ Bailey LB, Rampersaud GC, Kauwell GP. Folic acid supplements and fortification affect the risk for neural tube defects, vascular disease and cancer: evolving science. J Nutr. (2003)
151. ^ Choi JH, et al. Contemporary issues surrounding folic Acid fortification initiatives. Prev Nutr Food Sci. (2014)
152. ^ Giovannucci E, et al. Multivitamin use, folate, and colon cancer in women in the Nurses’ Health Study. Ann Intern Med. (1998)
153. ^ Cole et al.. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA. (2007)
154. ^ Hirsch S, et al. Colon cancer in Chile before and after the start of the flour fortification program with folic acid. Eur J Gastroenterol Hepatol. (2009)
155. ^ Mattson MP. Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol Rev. (1997)
156. ^ Triantafyllou NI et al.. Folate and vitamin B12 levels in levodopa-treated Parkinson’s disease patients: their relationship to clinical manifestations, mood and cognition. Parkinsonism Relat Disord. (2008)
157. ^ Triantafyllou NI et al.. The influence of levodopa and the COMT inhibitor on serum vitamin B12 and folate levels in Parkinson’s disease patients. Eur Neurol. (2007)
158. ^ Zoccolella S et al.. Plasma homocysteine levels in Parkinson’s disease: role of antiparkinsonian medications. Parkinsonism Relat Disord. (2005)
159. ^ Lamberti P, et al. Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson’s disease patients. Mov Disord. (2005)
160. ^ Heikkinen H, et al. Entacapone improves the availability of L-dopa in plasma by decreasing its peripheral metabolism independent of L-dopa/carbidopa dose. Br J Clin Pharmacol. (2002)
161. ^ Naughton CA, et al. Folate absorption in alcoholic pigs: in vitro hydrolysis and transport at the intestinal brush border membrane. Am J Clin Nutr. (1989)
162. ^ Halsted CH, Robles EA, Mezey E. Intestinal malabsorption in folate-deficient alcoholics. Gastroenterology. (1973)
163. ^ Herbet V, Zalusky R, and Davidson CS. Correlation of folate deficiency with alcoholism and associated macrocytosis, anemia, and liver disease. Ann Intern Med. (1963)
164. ^ a b Halsted CH, et al. Metabolic interactions of alcohol and folate. J Nutr. (2002)
165. ^ Halsted C et al.. Decreased Jejunal Uptake of Labeled Folic Acid (3H-PGA) in Alcoholic Patients: Roles of Alcohol and Nutrition. NEJM. (1971)
166. ^ McMartin KE, et al. Study of dose-dependence and urinary folate excretion produced by ethanol in humans and rats. Alcohol Clin Exp Res. (1986)
167. ^ a b Russell RM et al.. Increased urinary excretion and prolonged turnover time of folic acid during ethanol ingestion. Am J Clin Nutr. (1983)
168. ^ Tamura T, Halsted CH. Folate turnover in chronically alcoholic monkeys. J Lab Clin Med. (1983)
169. ^ a b Lieber CS et al.. S-adenosyl-L-methionine attenuates alcohol-induced liver injury in the baboon. Hepatology. (1990)
170. ^ a b Lu SC, et al. Changes in methionine adenosyltransferase and S-adenosylmethionine homeostasis in alcoholic rat liver. Am J Physiol Gastrointest Liver Physiol. (2000)
171. ^ Mato JM et al.. S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. J Hepatol. (1999)
172. ^ a b Amilburu A, et al. Inhibition of intestinal absorption of 5-methyltetrahydrofolate by fluoxetine. J Phys Biochem. (2001)
173. ^ a b Butterworth CE Jr, Tamura T. Folic acid safety and toxicity: a brief review. Am J Clin Nutr. (1989)
174. ^ van der Westhuyzen J, Metz J. Tissue S-adenosylmethionine levels in fruit bats (Rousettus aegyptiacus) with nitrous oxide-induced neuropathy. Br J Nutr. (1983)
175. ^ van der Westhuyzen J, Fernandes-Costa F, Metz J. Cobalamin inactivation by nitrous oxide produces severe neurological impairment in fruit bats : protection by methionine and aggravation by folates. Life Sci. (1982)